Gastroesophageal reflux disease and sleep disturbances

Journal of Gastroenterology

Volumn 47, Issue 7, 2012, Pages 760-769

  Fujiwara, Yasuhiro ^a   Arakawa, Tetsuo ^a   Fass, Ronnie ^b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Gastroesophageal reflux disease; Proton pump inhibitor; Quality of life; Sleep disturbance

Indexed keywords

BENZODIAZEPINE; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; ZOLPIDEM;

ACTIMETRY; ADD ON THERAPY; AROUSAL; DISEASE ASSOCIATION; DOSAGE SCHEDULE COMPARISON; EVENING DOSAGE; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERALGESIA; LIFESTYLE MODIFICATION; MEAL; MORNING DOSAGE; NIGHT; NIGHTTIME REFLUX; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SALIVATION; SLEEP; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP DURATION; SLEEP PARAMETERS; SLEEP QUALITY; STOMACH EMPTYING; SWALLOWING;

FEEDING BEHAVIOR; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; LIFE STYLE; PROTON PUMP INHIBITORS; QUALITY OF LIFE; SLEEP DISORDERS; TIME FACTORS;

EID: 84864968270     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-012-0601-4     Document Type: Review

References (68)

1. Carskadon MA, Dement WC. Normal human sleep: an overview. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. 4th ed. Philadelphia: Elsevier Saunders; 2005. p. 13-23.
2. Czeisler CA, Winkelman JW, Richardson GS. Sleep disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo JL, editors. Harrison's principles of internal medicine. 17th ed. New York: McGraw Hill Medical; 2008. p. 171-80.
3. Vakil N, van Zanten SV, Kahrilas P, Dent J, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900-20.
4. The Gallup Organization. A Gallup Organization National Survey: HB Across America. Princeton. 1998, 2000.
5. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol. 2009;44:518-34.
6. Suganuma N, Shigedo Y, Adachi H, Watanabe T, Kumano-Go T, Terashima K, et al. Association of gastroesophageal reflux disease with weight gain and apnea, and their disturbance on sleep. Psychiatry Clin Neurosci. 2001;55:255-6.
7. Farup C, Kleinman L, Sloan S, Ganoczy D, Chee E, Lee C, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med. 2001;161:45-52.
8. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487-93.
9. Fass R, Quan SF, O'Connor GT, Ervin A, Iber C. Predictors of heartburn during sleep in a large prospective cohort study. Chest. 2005;127:1658-66.
10. Mody R, Bolge SC, Kannan H, Fass R. Effects of gastroesophageal reflux disease on sleep and outcomes. Clin Gastroenterol Hepatol. 2009;7:953-9.
11. Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil. 2010;16:22-9.
12. Kusano M, Kouzu T, Kawano T, Ohara S. Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population. J Gastroenterol. 2008;43:833-41.
13. Fujiwara Y, Kohata Y, Kaji M, Nebiki H, Yamasaki T, Sasaki E, et al. Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole. Digestion. 2010;81:135-41.
14. Orr WC. Sleep-related gastro-oesophageal reflux as a distinct clinical entity. Aliment Pharmacol Ther. 2010;31:47-56.
15. Gerson LB, Fass R. A systematic review of the definitions, prevalence, and response to treatment of nocturnal gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2009;7:372-8.
16. Adachi K, Fujishiro H, Katsube T, Yuki M, Ono M, Kawamura A, et al. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J Gastroenterol Hepatol. 2001;16:1191-6.
17. Orr WC, Lackey C, Robinson MG, Johnson LF, Welsh JD. Esophageal acid clearance during sleep in patients with Barrett's esophagus. Dig Dis Sci. 1988;33(6):654-9.
18. Moore JG. Circadian dynamics of gastric acid secretion and pharmacodynamics of H2 receptor blockade. Ann N Y Acad Sci. 1991;618:150-8.
19. Reinberg A, Smolensky MH. Biological rhythms and medicine: cellular, metabolic, physiopathologic, and pharmacologic aspects. New York: Springer; 1983.
20. Stacher G, Presslich B, Stärker H. Gastric acid secretion and sleep stages during natural night sleep. Gastroenterology. 1975;68:1449-55.
21. Peghini PL, Katz PO, Castell DO. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects. Gastroenterology. 1998;115:1335-9.
22. Katsube T, Adachi K, Kawamura A, Amano K, Uchida Y, Watanabe M, et al. Helicobacter pylori infection influences nocturnal gastric acid breakthrough. Aliment Pharmacol Ther. 2000;14:1049-56.
23. Fass R. Proton pump inhibitor failure-what are the therapeutic options? Am J Gastroenterol. 2009;104(Suppl 2):S33-8.
24. Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology. 1987;93:515-8.
25. Mittal RK. Pathophysiology of gastroesophageal reflux: motility factors. J Gastroenterol. 2003;38(suppl 15):7-12.
26. Iwakiri K, Sugiura T, Hayashi Y, Kotoyori M, Kawakami A, Makino H, et al. Esophageal motility in Japanese patients with Barrett's esophagus. J Gastroenterol. 2003;38:1036-41.
27. Dent J, Dodds WJ, Friedman RH, Sekiguchi T, Hogan WJ, Arndorfer RC, et al. Mechanism of gastroesophageal reflux in recumbent asymptomatic human subjects. J Clin Invest. 1980;65:256-67.
28. Pasricha PJ. Effect of sleep on gastroesophageal physiology and airway protective mechanisms. Am J Med. 2003;115(Suppl 3A):114S-8S.
29. Orr WC. Gastrointestinal functioning during sleep: a new horizon in sleep medicine. Sleep Med Rev. 2001;5:91-101.
30. Kahrilas PJ, Dodds WJ, Dent J, Haeberle B, Hogan WJ, Arndorfer RC. Effect of sleep, spontaneous gastroesophageal reflux, and a meal on upper esophageal sphincter pressure in normal human volunteers. Gastroenterology. 1987;92:466-71.
31. Schneyer LH, Pigman W, Hanahan L, Gilmore RW. Rate of flow of human parotid, sublingual, and submaxillary secretions during sleep. J Dent Res. 1956;35:109-14.
32. Lear CS, Flanagan JB Jr, Moorrees CF. The frequency of deglutition in man. Arch Oral Biol. 1965;10:83-100.
33. Freidin N, Fisher MJ, Taylor W, Boyd D, Surratt P, McCallum RW, et al. Sleep and nocturnal acid reflux in normal subjects and patients with reflux oesophagitis. Gut. 1991;32:1275-9.
34. Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Watanabe T, Tominaga K, et al. Prevalence of gastroesophageal reflux disease and gastroesophageal reflux disease symptoms in Japan. J Gastroenterol Hepatol. 2005;20:26-9.
35. Watanabe Y, Fujiwara Y, Shiba M, Watanabe T, Tominaga K, Oshitani N, et al. Cigarette smoking and alcohol consumption associated with gastro-oesophageal reflux disease in Japanese men. Scand J Gastroenterol. 2003;38:807-11.
36. Fujiwara Y, Higuchi K, Watanabe Y, Shiba M, Sasaki E, Watanabe T, et al. Association between sleep duration and gastroesophageal reflux disease. Jpn Gastroenterol. 2005;128:A384 (abstract).
37. Morse CA, Quan SF, Mays MZ, Green C, Stephen G, Fass R. Is there a relationship between obstructive sleep apnea and gastroesophageal reflux disease? Clin Gastroenterol Hepatol. 2004;2(9):761-8.
38. Fass R. Gastroesophageal reflux disease and sleep. J Clin Gastroenterol. 2007;41(Suppl 2):S154-9.
39. Mizuta Y, Takashima F, Shikuwa S, Ikeda S, Kohno S. Is there a specific linkage between obstructive sleep apnea syndrome and gastroesophageal reflux disease? Dig Endosc. 2006;18:88-97.
40. Orr WC, Goodrich S, Robert J. The effect of acid suppression on sleep patterns and sleep-related gastro-oesophageal reflux. Aliment Pharmacol Ther. 2005;21:103-8.
41. Poh CH, Allen L, Gasiorowska A, Navarro-Rodriguez T, Quan SF, Malagon I, et al. Conscious awakenings are commonly associated with acid reflux events in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2010;8:851-7.
42. Allen L, Poh CH, Gasiorowska A, Malagon I, Navarro-Rodriguez T, Cui H, et al. Increased oesophageal acid exposure at the beginning of the recumbent period is primarily a recumbentawake phenomenon. Aliment Pharmacol Ther. 2010;32:787-94.
43. Poh CH, Gasiorowska A, Allen L, Navarro-Rodriguez T, Mizyed I, Powers J, et al. Reassessment of the principal characteristics of gastroesophageal reflux during the recumbent period using integrated actigraphy-acquired information. Am J Gastroenterol. 2010;105:1024-31.
44. Poh CH, Allen L, Malagon I, Gasiorowska A, Navarro-Rodriguez T, Powers J, et al. Riser's reflux-an eye-opening experience. Neurogastroenterol Motil. 2010;22:387-94.
45. Dickman R, Parthasarathy S, Malagon IB, Jones P, Han B, Powers J, et al. Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groups. Aliment Pharmacol Ther. 2007;26:41-8.
46. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Standards of Practice Committee; American Academy of Sleep Medicine, et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep. 2007;30:519-29.
47. Schey R, Dickman R, Parthasarathy S, Quan SF, Wendel C, Merchant J, et al. Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology. 2007;133:1787-95.
48. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166:965-71.
49. Fujiwara Y, Machida A, Watanabe Y, Shiba M, Tominaga K, Watanabe T, et al. Association between dinner-to-bed time and gastro-esophageal reflux disease. Am J Gastroenterol. 2005;100:2633-6.
50. Piesman M, Hwang I, Maydonovitch C, Wong RK. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am J Gastroenterol. 2007;102:2128-34.
51. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997;112:1798-810.
52. Dimarino AJ Jr, Banwait KS, Eschinger E, Greenberg A, Dimarino M, Doghramji K, et al. The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters. Aliment Pharmacol Ther. 2005;22:325-9.
53. Johnson DA, Orr WC, Crawley JA, Traxler B, McCullough J, Brown KA, et al. Effect of esomeprazole on nighttime heartburn and sleep quality in patients with GERD: a randomized, placebocontrolled trial. Am J Gastroenterol. 2005;100:1914-22.
54. Fass R. Effect of gastroesophageal reflux disease on sleep. J Gastroenterol Hepatol. 2010;25(Suppl 1):S41-4.
55. Hatlebakk JG, Katz PO, Kuo B, Castell DO. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Aliment Pharmacol Ther. 1998;12:1235-40.
56. Pehlivanov ND, Olyaee M, Sarosiek I, McCallum RW. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study. Aliment Pharmacol Ther. 2003;18:883-90.
57. Katz PO, Hatlebakk JG, Castell DO. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole. Aliment Pharmacol Ther. 2000;14:709-14.
58. Shimatani T, Inoue M, Kuroiwa T, Horikawa Y. Rabeprazole 10 mg twice daily is superior to 20 mg once daily for night-time gastric acid suppression. Aliment Pharmacol Ther. 2004;19:113-22.
59. Ours TM, Fackler WK, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol. 2003;98:545-50.
60. Rackoff A, Agrawal A, Hila A, Mainie I, Tutuian R, Castell DO. Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy. Dis Esophagus. 2005;18:370-3.
61. Castell D. Review of immediate-release omeprazole for the treatment of gastric acid-related disorders. Expert Opin Pharmacother. 2005;6:2501-10.
62. Behm BW, Peura DA. Dexlansoprazole MR for the management of gastroesophageal reflux disease. Expert Rev Gastroenterol Hepatol. 2011;5:439-45.
63. Nwokolo CU, Prewett EJ, Sawyerr AM, Hudson M, Lim S, Pounder RE. Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study. Gastroenterology. 1991;101:948-53.
64. Galmiche JP, Hatlebakk J, Attwood S, Ell C, Fiocca R, Eklund S, Långström G, Lind T, LOTUS Trial Collaborators. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305:1969-77.
65. Cohen JA, Arain A, Harris PA, Byrne DW, Holzman MD, Sharp KW, et al. Surgical trial investigating nocturnal gastroesophageal reflux and sleep (STINGERS). Surg Endosc. 2003;17:394-400.
66. Rushnak MJ, Leevy CM. Effect of diazepam on the lower esophageal sphincter. A double-blind controlled study. Am J Gastroenterol. 1980;73:127-30.
67. Gagliardi GS, Shah AP, Goldstein M, Denua-Rivera S, Doghramji K, Cohen S, et al. Effect of zolpidem on the sleep arousal response to nocturnal esophageal acid exposure. Clin Gastroenterol Hepatol. 2009;7:948-52.
68. Orr WC, Goodrich S, Fernström P, Hasselgren G. Occurrence of nighttime gastroesophageal reflux in disturbed and normal sleepers. Clin Gastroenterol Hepatol. 2008;6:1099-104.